Hong Kong billionaire Li Ka-shing funds Asia's first scalpel-free kidney tumour trials
Hong Kong billionaire Li Ka-shing is paying for 30 patients to join Asia's first trials of a non-invasive ultrasound treatment for kidney tumours.
Li Ka-shing
Skip to content
Hong Kong billionaire Li Ka-shing is paying for 30 patients to join Asia's first trials of a non-invasive ultrasound treatment for kidney tumours.